eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
5/2024
vol. 41
 
Share:
Share:
Letter to the Editor

Primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma with aberrant CD56 expression: a rare case report

Shuaihantian Luo
1
,
Yingdan Chen
2
,
Guiying Zhang
1

  1. Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China
  2. Department of Dermatology, People’s Hospital of Longhua, Shenzhen, Guangdong, China
Adv Dermatol Allergol 2024; XLI (5): 538-541
Online publish date: 2024/10/24
Article file
- Primary.pdf  [0.33 MB]
Get citation
 
 
1. Berti E, Tomasini D, Vermeer MH et al. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol 1999; 155: 483-92.
2. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-85.
3. Gormley RH, Hess SD, Anand D, et al. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma. J Am Acad Dermatol 2010; 62: 300-7.
4. Wobser M, Reinartz T, Roth S, et al. Cutaneous CD8+ cytotoxic T-cell lymphoma infiltrates: clinicopathological correlation and outcome of 35 cases. Oncol Ther 2016; 4: 199-210.
5. Kim SK, Kim YC, Kang HY. Primary cutaneous aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma with atypical presentation. J Dermatol 2006; 33: 632-4.
6. Wang Y, Li T, Tu P, et al. Primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma clinically simulating pyoderma gangrenosum. Clin Exp Dermatol 2009; 34: e261-2.
7. Santucci M, Pimpinelli N, Massi D, et al. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer 2003; 97: 610-27.
8. Lozzi GP, Massone C, Citarella L, et al. Rimming of adipocytes by neoplastic lymphocytes: a histopathologic feature not restricted to subcutaneous T-cell lymphoma. Am J Dermatopathol 2006; 28: 9-12.
9. Benetatos L, Dova L, Baxevanos G, et al. Peripheral blood flow cytometry based diagnosis in primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: implications for more extensive use. Cytometry B Clin Cytom 2009; 76: 102-6.
10. Kato K, Oh Y, Takita J, et al. Molecular genetic and cytogenetic analysis of a primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma. Int J Hematol 2016; 103: 196-201.
11. Martinez-Escala ME, Kantor RW, Cices A, et al. CD8(+) mycosis fungoides: a low-grade lymphoproliferative disorder. J Am Acad Dermatol 2017; 77: 489-96.
12. Mani V, George R, Vijayakumar K, et al. Type D lymphomatoid papulosis simulating aggressive epidermotropic cytotoxic lymphoma. Indian J Pathol Microbiol 2016; 59: 81-3.
13. Geller S, Myskowski PL, Pulitzer M. NK/T-cell lymphoma, nasal type, gammadelta T-cell lymphoma, and CD8-positive epidermotropic T-cell lymphoma-clinical and histopathologic features, differential diagnosis, and treatment. Semin Cutan Med Surg 2018; 37: 30-8.
14. Kimby E. Management of advanced-stage peripheral T-cell lymphomas. Curr Hematol Malig Rep 2007; 2: 242-8.
15. Lee K, Evans MG, Yang L, et al. Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway. Blood 2021; 138: 2435-40.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.